記事 BE Ventures Leads AcroCyte Therapeutics’ US$10 Million Financing Round to Accelerate Clinical Translation of the R³CE® Platform and U.S. Expansion Professor Ying-Chih Chang Read More » 2026年8月26日
記事 From FDA Clearance to Organ Transplantation: ANIVIA’s U.S. Commercialization Pathway for Taiwan’s Therapeutic MedTech Henry Lin, Co-founder and Read More » 2026年8月20日